TABLE 1.
Carbapenemase gene and plasmid curing
| Strain | ST | Carbapenemase gene and/or plasmid | Reference or source | Target gene(s) | Target sequence(s) (N20) | Curing efficiency (%)b |
|---|---|---|---|---|---|---|
| Strains containing plasmid and resistance genes | ||||||
| K. pneumoniae 13001 | 258 | blaKPC-2, IncFIIK-pKpQIL | 25 | IncFIIK repA | GGTTTTTAACCTGTGAATAG | 98.6 ± 2.4 |
| IncFIB(pQIL) repB | ACTGACTTCAAGGTGTGGGT | 100 ± 0 | ||||
| parA | TAAGGTATTTCAACGTGGAA | 99.3 ± 1.2 | ||||
| blaKPC | CAATTTGTTGCTGAAGGAGT | 98.6 ± 1.2 | ||||
| K. pneumoniae Kp97_58 | 111 | blaKPC-2, IncN | 10 | IncN repA | GAGCAAGACTTTCATAAAGG | 97.9 ± 2.1 |
| blaKPC | CAATTTGTTGCTGAAGGAGT | 96.5 ± 2.4 | ||||
| E. coli 53433 | 167 | blaNDM-5, IncX3 | This study | IncX3 repA | AATGTTAGATGATGATATTT | 99.3 ± 1.2 |
| blaNDM | CCCAACGGTGATATTGTCAC | 97.2 ± 4.8 | ||||
| K. pneumoniae 49210 | 23 | blaOXA-48, IncL- pOXA48 | This study | IncL repA | ATATCATGCGTTTCTAAGCG | 100 ± 0 |
| blaOXA-48-like | CACCAAGTCTTTAAGTGGGA | 99.3 ± 1.2 | ||||
| IncL repA and blaOXA-48-likec | ATATCATGCGTTTCTAAGCG and CACCAAGTCTTTAAGTGGGA | 100 ± 0c | ||||
| Strains containing resistance genes | ||||||
| E. hormaechei 34978 | 171 | blaKPC-3 | 26 | blaKPC | CAATTTGTTGCTGAAGGAGT | 95.8 ± 2.1 |
| E. xiangfangensis 34399 | 114 | blaKPC-3 | 26 | blaKPC | CAATTTGTTGCTGAAGGAGT | 95.1 ± 2.4 |
| E. coli 28009 | 131 | blaKPC-2 | 27 | blaKPC | CAATTTGTTGCTGAAGGAGT | 97.2 ± 3.2 |
| S. marcescens SmN01 | a | blaNDM-7 | 28 | blaNDM | CCCAACGGTGATATTGTCAC | 94.4 ± 3.2 |
| K. pneumoniae 51933 | 307 | blaOXA-48 | 29 | blaOXA-48-like | CACCAAGTCTTTAAGTGGGA | 98.6 ± 1.2 |
Not examined.
The values shown are the mean ± SD of three independent experiments.
cThe double sgRNAs were generated by inserting the IncL sgRNA in pCasCure-OXA48-Apr at the PstI and XmaI restriction sites. The curing result was obtained at 4 h of incubation with 0.1% arabinose treatment.